Rivastigmine transdermal system receives FDA approval for Alzheimer's disease

被引：0
|
作者：
Ralat, Jose
机构：
来源：
CNS SPECTRUMS | 2007年 / 12卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：581 / 582
页数：2
相关论文
共 50 条
  • [21] Treatment of apathy in Alzheimer's disease with transdermal rivastigmine: report of three cases
    Granero, Alessandra Lamas
    Lucchetti, Giancarlo
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2010, 32 (01) : 94 - 95
  • [22] GELLAN GUM RECEIVES FDA APPROVAL
    不详
    FOOD TECHNOLOGY, 1990, 44 (11) : 88 - 90
  • [23] BTG RECEIVES FDA APPROVAL FOR HGH
    不详
    EUROPEAN CHEMICAL NEWS, 1995, 63 (1670): : 29 - 29
  • [24] Nivolumab Receives Expanded FDA Approval
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 738 - 738
  • [25] Liposuction laser receives FDA approval
    不详
    EXPERT REVIEW OF MEDICAL DEVICES, 2005, 2 (02) : 136 - 136
  • [26] Insulin glulisine receives FDA approval
    Holt, RIG
    DIABETES OBESITY & METABOLISM, 2004, 6 (05): : 397 - 397
  • [27] HUMAN INSULIN RECEIVES FDA APPROVAL
    不详
    CLINICAL PEDIATRICS, 1983, 22 (05) : 367 - 367
  • [28] Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy
    Farlow, Martin R.
    Grossberg, George T.
    Meng, Xiangyi
    Olin, Jason
    Somogyi, Monique
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (12) : 1236 - 1243
  • [29] Rivastigmine Transdermal Patch and Capsule in Alzheimer's Disease: Influence of Disease Stage on Response to Therapy
    Farlow, Martin R.
    Grossberg, George T.
    Meng, Xiangyi
    Somogyi, Monique
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S121 - S121
  • [30] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline
    Evans, John Grimley
    Iakovidou, Vasso
    Tsolaki, Magda
    Holt, Francesca E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
12345